The thinking around carrier screening is changing, with the leading medical associations agreeing that all women who are considering pregnancy or are currently pregnant should be offered carrier screening for cystic fibrosis and spinal muscular atrophy.
The American Congress of Obstetricians and Gynecologists (ACOG) and American College of Medical Genetics and Genomics (ACMG) currently have guidelines related to screening for mutations for more than a dozen specific conditions.
With a wide array of testing choices, Integrated Genetics can help meet a wide array of patient needs. Our carrier screening offerings include Inheritest—with four panels: Comprehensive, Ashkenazi Jewish, Society-Guided, and Core—and many single-gene tests for patients who may only want to screen for a specific disorder, such as cystic fibrosis, spinal muscular atrophy, or fragile X syndrome.
Focused partner testing and a “single source”
Should a patient receive a positive screen result, we offer full-gene sequencing for her reproductive partner to identify more disorder-causing variants and at-risk pregnancies.
Additionally, using Integrated Genetics as your single source for carrier screening, prenatal testing (eg, serum screening and noninvasive prenatal testing), prenatal diagnostic testing, and hereditary cancer testing creates efficiencies in ordering and processing tests for you, your staff, and your patients.
Integrated Genetics is one of the only companies that can offer this true continuity of care. Explore other testing options and services below.
Other testing options
In addition to carrier screening, we also offer: serum screening and noninvasive prenatal testing (NIPT, sometimes called NIPS or cell-free DNA), including the pioneering whole-genome NIPT; diagnostic testing that can be used on prenatal and products of conception (POC) samples, as well as pediatric, cord blood or adult samples; and hereditary cancer screening.